Employees: 03 (2023.0)Legal category: 5485Size: PMECreation date: 1999-10-25 (26 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: PERIGNY (17180), Charente-Maritime
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
SELARL PHARMACIE DE ROMPSAY : revenue, balance sheet and financial ratios
SELARL PHARMACIE DE ROMPSAY is a French company
founded 26 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in PERIGNY (17180),
this company of category PME
shows in 2018 a revenue of 2.1 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SELARL PHARMACIE DE ROMPSAY (SIREN 428171219)
Indicator
2024
2023
2022
2021
2020
2019
2018
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
2 082 552 €
Net income
-31 585 €
35 909 €
32 171 €
-13 491 €
555 €
-47 710 €
13 159 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
21 601 €
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
0.6%
Revenue and income statement
In 2024, SELARL PHARMACIE DE ROMPSAY records a net loss of 32 k€. This deficit will reduce equity on the balance sheet.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
-31 585 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 17%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 65%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
16.644%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
64.858%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution SELARL PHARMACIE DE ROMPSAY
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2018
2019
2020
2021
2022
2023
2024
Debt ratio
31.137
13.082
41.223
44.668
35.7
25.243
16.644
Financial autonomy
60.705
65.948
58.17
56.344
60.248
63.515
64.858
Repayment capacity
11.025
None
None
None
None
None
None
Cash flow / Revenue
1.003%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
16.642024
2022
2023
2024
Q1: 16.46
Med: 58.48
Q3: 154.77
Good-6 pts over 3 years
In 2024, the debt ratio of SELARL PHARMACIE DE ROMPSAY (16.64) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
64.86%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Good
In 2024, the financial autonomy of SELARL PHARMACIE DE ROMPSAY (64.9%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 151.53. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
151.535
Liquidity indicators evolution SELARL PHARMACIE DE ROMPSAY
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2018
2019
2020
2021
2022
2023
2024
Liquidity ratio
169.294
114.172
208.512
217.277
219.172
223.207
151.535
Interest coverage
15.453
None
None
None
None
None
None
Sector positioning
Liquidity ratio
151.532024
2022
2023
2024
Q1: 129.46
Med: 182.14
Q3: 260.79
Average-21 pts over 3 years
In 2024, the liquidity ratio of SELARL PHARMACIE DE ROMPSAY (151.53) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution SELARL PHARMACIE DE ROMPSAY
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2018
2019
2020
2021
2022
2023
2024
Operating WCR
162 127 €
0 €
0 €
0 €
0 €
0 €
0 €
Inventory turnover (days)
33
0
0
0
0
0
0
Customer payment term (days)
6
0
0
0
0
0
0
Supplier payment term (days)
32
0
0
0
0
0
0
Positioning of SELARL PHARMACIE DE ROMPSAY in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SELARL PHARMACIE DE ROMPSAY with other companies in the same sector:
Frequently asked questions about SELARL PHARMACIE DE ROMPSAY
What is the revenue of SELARL PHARMACIE DE ROMPSAY ?
The revenue of SELARL PHARMACIE DE ROMPSAY in 2018 is 2.1 M€.
Is SELARL PHARMACIE DE ROMPSAY profitable?
SELARL PHARMACIE DE ROMPSAY recorded a net loss in 2024.
Where is the headquarters of SELARL PHARMACIE DE ROMPSAY ?
The headquarters of SELARL PHARMACIE DE ROMPSAY is located in PERIGNY (17180), in the department Charente-Maritime.
Where to find the tax return of SELARL PHARMACIE DE ROMPSAY ?
The tax return of SELARL PHARMACIE DE ROMPSAY is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SELARL PHARMACIE DE ROMPSAY operate?
SELARL PHARMACIE DE ROMPSAY operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart